May 2, 2013 / 6:47 AM / 4 years ago

Spain's Grifols says Q1 net profit up 19 pct y/y

MADRID, May 2 (Reuters) - Spanish pharmaceutical company Grifols said on Thursday net profit rose 19 percent in the first quarter of 2013 from a year earlier to 115.7 million euros ($152.6 million), boosted by overseas sales, especially Latin America and Asia.

Including the one-time costs from the acquisition of U.S. company Talecris last June, the world’s third-largest blood products maker said net profit rose 34.8 percent to 91 million euros.

Barcelona-based Grifols, which generates over 90 percent of its sales outside its recession-hit home market, said first quarter revenue increased 2.6 percent to 683.7 million euros. ($1 = 0.7580 euros) (Reporting By Paul Day; Editing by Carlos Ruano)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below